Converge

AstraZeneca and Verge partner to discover AI-driven drugs for rare neurodegenerative diseases

AstraZeneca and Verge partner to discover AI-driven drugs for rare neurodegenerative diseases

Anika Sharma

Verge Genomics is expanding its roster of Big Pharma partnerships by teaming up with AstraZeneca in a substantial $42 million ...